Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol.

Vignetti, Marco

Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. [electronic resource] - Blood May 2007 - 3676-8 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0006-4971

10.1182/blood-2006-10-052746 doi


Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Benzamides
Disease-Free Survival
Female
Follow-Up Studies
Fusion Proteins, bcr-abl--genetics
Humans
Imatinib Mesylate
Male
Middle Aged
Piperazines--administration & dosage
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Pyrimidines--administration & dosage
Remission Induction
Steroids--administration & dosage
Survival Rate